FDA Approves Trulicity, Once-Weekly Injection for Type 2 Diabetes On Thursday the United States Food and Drug Administration approved Trulicity, by Eli Lilly and Company, a once weekly, injectable GLP-1 treatment for adults with Type 2 diabetes.
